In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inside Lilly Research Laboratories: A Discussion With Jan Lundberg

Executive Summary

Unbowed by a string of recent pipeline setbacks, Lilly Research Labs' new leader speaks out about his company's current trajectory and his belief in ongoing initiatives like Chorus and a mirror fund as Lilly attempts to bridge its patent cliff.
Advertisement

Related Content

Lilly Antibody Proves Ineffective In Rheumatoid Arthritis, But Lupus Trials Continue
Lilly Antibody Proves Ineffective In Rheumatoid Arthritis, But Lupus Trials Continue
Alzheimer's Dx: An Essential Piece of the Puzzle
Lilly's Evolving Corporate Venture Model
Lilly To Cease Development Of Alzheimer's Drug
Lilly To Cease Development Of Alzheimer's Drug
Lilly Tries to Buy Time
Lilly Tries to Buy Time
Lilly's Chorus Experiment
Lilly's Asset Management Program

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel